Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer

Go back to Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
(NASDAQ: QTTB) Delayed: 10.47 --0 (-0%)
Previous Close $10.47    52 Week High
Open $10.47    52 Week Low
Day High $10.47    P/E N/A 
Day Low $10.47    EPS
Volume 22